Wird geladen...

Use of the Trypanosoma cruzi Recombinant Complement Regulatory Protein To Evaluate Therapeutic Efficacy following Treatment of Chronic Chagasic Patients

One of the greatest concerns in Chagas' disease is the absence of reliable methods for the evaluation of chemotherapy efficacy in treated patients. The tests available to evaluate cure after the specific treatment are the complement-mediated lysis (CoML) and flow cytometry tests, but they are n...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Meira, Wendell S. F., Galvão, Lúcia M. C., Gontijo, Eliane D., Machado-Coelho, George L. L., Norris, Karen A., Chiari, Egler
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2004
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC344465/
https://ncbi.nlm.nih.gov/pubmed/14766840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.2.707-712.2004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!